Patents by Inventor Jere W. McBride

Jere W. McBride has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC IMMUNOGENIC POLYPEPTIDES
    Publication number: 20240018195
    Abstract: Provided herein are chimeric polypeptides that may be used, e.g., for the diagnosis of or vaccination against Ehrlichia chaffeensis and/or Ehrlichia canis.
    Type: Application
    Filed: September 5, 2023
    Publication date: January 18, 2024
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, David H. WALKER
  • Chimeric immunogenic polypeptides
    Patent number: 11780892
    Abstract: Provided herein are chimeric polypeptides that may be used, e.g., for the diagnosis of or vaccination against Ehrlichia chaffeensis and/or Ehrlichia canis.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: October 10, 2023
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, David H. Walker
  • PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION
    Publication number: 20230210973
    Abstract: Methods and compositions for diagnosing and vaccinating against Ehrlichia canis and Ehrlichia chaffeensis are provided.
    Type: Application
    Filed: May 10, 2021
    Publication date: July 6, 2023
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, David H. WALKER, Tian LUO, Jignesh PATEL
  • EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS
    Publication number: 20220356231
    Abstract: Provided herein are immunogenic compositions that may be used, in some aspects, to induce an immune response against an Ehrlichia such as Ehrlichia cams. In some embodiments, the immunogenic composition comprises an E. canis bacterin and/or adjuvant, such as for example an emulsion or liposomal adjuvant. Related methods such as for diagnosis of or vaccination against ehrlichiosis are also provided.
    Type: Application
    Filed: July 13, 2020
    Publication date: November 10, 2022
    Applicants: Research Development Foundation, Zoetis Services LLC
    Inventors: Jere W. McBRIDE, Paul J. DOMINOWSKI, Suman MAHAN, Jason J. MILLERSHIP, Duncan M. MWANGI, Sharath RAI, Sharon M. WAPPEL
  • Immunoreactive protein orthologs of and
    Patent number: 11459379
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: October 4, 2022
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher K. Doyle
  • CHIMERIC IMMUNOGENIC POLYPEPTIDES
    Publication number: 20210292377
    Abstract: Provided herein are chimeric polypeptides that may be used, e.g., for the diagnosis of or vaccination against Ehrlichia chaffeensis and/or Ehrlichia canis.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 23, 2021
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, David H. WALKER
  • Chimeric immunogenic polypeptides
    Patent number: 11046734
    Abstract: Provided herein are chimeric polypeptides that may be used, e.g., for the diagnosis of or vaccination against Ehrlichia chaffeensis and/or Ehrlichia canis.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: June 29, 2021
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, David H. Walker
  • IMMUNOREACTIVE PROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSIS
    Publication number: 20200199205
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 25, 2020
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher K. DOYLE
  • CHIMERIC IMMUNOGENIC POLYPEPTIDES
    Publication number: 20200031877
    Abstract: Provided herein are chimeric polypeptides that may be used, e.g., for the diagnosis of or vaccination against Ehrlichia chaffeensis and/or Ehrlichia canis.
    Type: Application
    Filed: July 29, 2019
    Publication date: January 30, 2020
    Inventors: Jere W. McBRIDE, David H. WALKER
  • Vaccines and diagnostics for the ehrlichioses
    Patent number: 10131705
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: November 20, 2018
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Tian Luo
  • VACCINES AND DIAGNOSTICS FOR THE EHRLICHIOSES
    Publication number: 20180079803
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 22, 2018
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Tian LUO
  • Vaccines and diagnostics for the ehrlichioses
    Patent number: 9850295
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: December 26, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Tian Luo
  • Immunoreactive glycoprotein GP19 of
    Patent number: 9814768
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: November 14, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • IMMUNOREACTIVE PROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSIS
    Publication number: 20170204168
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 20, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher K. DOYLE
  • IMMUNOREACTIVE GLYCOPROTEIN GP19 OF EHRLICHIA CANIS
    Publication number: 20170173136
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 22, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher Kuyler DOYLE
  • VACCINES AND DIAGNOSTICS FOR THE EHRLICHIOSES
    Publication number: 20170166628
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 15, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Tian LUO
  • Immunoreactive protein orthologs of and
    Patent number: 9645148
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: May 9, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher K. Doyle
  • Immunoreactive glycoprotein GP19 of
    Patent number: 9605033
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: March 28, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher Kuyler Doyle
  • Immunoreactive glycoprotein GP19
    Patent number: 9605032
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: March 28, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Christopher K. Doyle
  • Vaccines and diagnostics for the ehrlichioses
    Patent number: 9605035
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: March 28, 2017
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Tian Luo